Monoubiquitination of PCNA is a critical event coordinating DNA damage tolerance pathways. We here report that translesion synthesis polymerase REV1 can promote PCNA-mUb via its preferential association with monoubiquitinated RAD18. PCNA monoubiquitination is one of the key factors for TLS pathway choice. So far, it remains unclear how TLS pathway is elaborately regulated. Here, we report that TLS polymerase REV1 can promote PCNA monoubiquitination after UV radiation. Further studies revealed that this stimulatory effect is mediated through the enhanced interaction between REV1 and ubiquitinated RAD18, which facilitates the release of nonubiquitinated RAD18 from ubiquitinated RAD18 trapping followed by more RAD18 recruiting to chromatin for its TLS function. Furthermore, we found that this stimulatory effect could also be detected after exposure to hydroxyurea or mitomycin C, but not methyl methanesulfonate (MMS), which is in line with the fact that ubiquitinated RAD18 could not be detected after exposure to MMS.
which becomes monoubiquitinated at Lys164 in mammalian cells following various DNA damage treatments that cause the replication fork stalling (Kannouche et al., 2004) . Monoubiquitinated PCNA (PCNA-mUb) exhibits an enhanced interaction with Y-family polymerases (Guo et al., 2006b; Parker et al., 2007; Guo et al., 2008; Waters et al., 2009) , and thus regulates them to access the replicative ensemble stalled at a lesion to execute their roles in lesion bypass. Given that PCNA-mUb promotes TLS pathway (Hoege et al., 2002; Moldovan et al., 2007; Chen et al., 2011) , many studies have been performed to understand how this modification happens in vivo (Hedglin and Benkovic, 2015) . In addition to the major E3 ubiquitin ligase RAD18, several other E3 ligases, like RNF8 (Zhang et al., 2008) and CRL cdt2 (Terai et al., 2010) , have been reported to regulate PCNA-mUb. Additionally, many factors, including SIVA1 (Han et al., 2014) , Spartan/C1orf124 (protein with sprT-like domain at the N terminus, also known as DVC1 [DNA damage protein targeting VCP]) (Centore et al., 2012) , MSH2 (MutS protein homolog 2) (Zlatanou et al., 2011; Lv et al., 2013) , BRCA1
(breast cancer 1) (Tian et al., 2013) , have also been found to regulate the RAD18-dependent PCNA-mUb. USP1 (ubiquitin-specific protease-1) also participates in the regulation of PCNA-mUb. It is a key deubiquitinase (DUB) for deubiquitinating PCNA-mUb (Huang et al., 2006) . Recently, it was reported that monoubiquitinated RAD18 (RAD18-Ub) also regulates PCNA-mUb and TLS activity (Zeman et al., 2014) . RAD18-Ub not only releases itself from chromatin (Zeman et al., 2014) , but also sequesters nonubiquitinated RAD18 from recruiting to chromatin.
During studying REV1's function(s) in TLS, we accidentally observed that REV1 affects PCNA-mUb. We found that REV1 can promote RAD18 accumulating at chromatin and PCNA-mUb after UV radiation. Further studies indicate that this stimulatory effect is mediated through the enhanced interaction between REV1 and
Journal of Cell Science • Advance article RAD18-Ub, which facilitates the release of nonubiquitinated RAD18 from RAD18-Ub trapping followed by more RAD18 recruiting to chromatin for its TLS function. Interestingly, this stimulatory effect could also be detected after treatments with hydroxyurea (HU) or mitomycin C (MMC), but not with methyl methanesulfonate (MMS) which leads to the loss of RAD18-Ub.
Results

REV1 promotes PCNA monoubiquitination
PCNA-mUb has been shown to interact with REV1 and mediated the latter to accumulate at UV-induced stalled replication sites. We are wondering whether REV1
conversely affects UV-induced PCNA monoubiquitination. To answer that question,
we transfected 293T cells with siRNA directed against human REV1 (siREV1) and examined the level of PCNA-mUb in the triton-insoluble fractions. We found that depletion of REV1 obviously decreased the level of PCNA-mUb in the presence and absence of UV radiation (Fig.1A) . Conversely, we found that over-expression of GFP-REV1 in 293T cells could increase the level of PCNA-mUb in the presence and absence of UV radiation (Fig.1B) . Interestingly, we found that the stimulatory effect of REV1 on PCNA-mUb is closely related to the level of REV1 expression. Higher amount of REV1 induced more PCNA to be monoubiquitinated (Fig. 1C) . These data indicate that REV1 could promote basal and UV-induced PCNA-mUb, which is intimately related to the level of REV1 expression. Additionally, we performed PCNA immunofluorescence and detected no obvious change in PCNA focus formation in cells either depletion or overexpression of REV1 (Fig. S1 ). This result is expectable because PCNA-mUb seems not necessary for its focus formation in cells either at S-phase or after damage treatments (Essers et al., 2005) .
REV1 promotes PCNA-mUb independent of Polη and USP1
Previous studies have shown that REV1 interacts with Polη (Guo et al., 2003) and (Fig. 2B) . Moreover, over-expression of REV1 could not reduce USP1 expression, either (Fig. 2C) . Additionally, we found that over-expression of REV1 still significantly promoted PCNA-mUb in the USP1-depleted cells (Fig. 2D ). These results indicate that the stimulatory effect of REV1 on PCNA-mUb is USP1-independent.
REV1 promotes PCNA-mUb via a RAD18-dependent manner
It is well established that the level of PCNA-mUb is positively regulated by the RAD6/RAD18 ubiquitin ligase complex (Hoege et al., 2002; Kannouche et al., 2004; Ulrich, 2009; Hedglin and Benkovic, 2015) . We are wondering whether REV1
promotes PCNA-mUb via a RAD18-dependent fashion. We first transfected GFP-REV1 into the control or RAD18 stable knockdown U2OS cells (Zhang et al., 2013) . We found that depletion of RAD18 significantly inhibited the stimulatory effect of REV1 on UV-induced PCNA-mUb (Fig. 2E) . However, considering that the RAD18 stable knockdown cells manifested an appreciable REV1-promoted PCNA-mUb, it is necessary to determine whether REV1 might also stimulate PCNA-mUb in a RAD18-independent manner. We then established a RAD18 knockout 293T cell line based on the TALEN technology. We found that the Journal of Cell Science • Advance article stimulatory effect of REV1 on UV-induced PCNA-mUb was completely abrogated in RAD18 knockout cells (Fig. 2F ). These results indicate that RAD18 mediates the REV1-promoted PCNA-mUb in the absence and presence of UV damage.
REV1 facilitates RAD18 but not RPA32 accumulation on chromatin
We then determined how RAD18 mediates REV1-promoted PCNA-mUb. We first compared the level of RAD18 in the control and REV1-depleted cells and found that REV1 depletion does not affect RAD18 expression (Fig. 3A) . However, depletion of REV1 resulted in a decreased chromatin association of RAD18 (Fig. 3B) . To avoid the off-target effect of siRNA, we repeated the experiment with another individual siRNA (siREV1-2) and obtained similar result (Fig. 3C) . Additionally, depletion of REV1 did not produce an obvious difference in the distribution of RAD18-mUb/RAD18 in the soluble fraction (Fig. 3C) . Considering that only a small fraction of total RAD18 associated with chromatin even after UV radiation in our system ( Fig. S2A) , we speculate that the amount of RAD18 released from the chromatin upon REV1 knockdown might be not enough to produce an obvious difference in the distribution of RAD18-mUb/RAD18 in the soluble fraction. Then, we examined whether REV1 regulates UV-induced RAD18 focus formation. We transfected U2OS cells with two independent siRNAs (siREV1-1 & siREV1-2) and found that knockdown of REV1 led to an obvious reduction in RAD18 focus formation after UV damage ( Fig. 3D & E) , although depletion of REV1 had no obvious effect on the RAD18 global nuclear staining ( The UBM domains of REV1 are required for its stimulatory effect on
PCNA-mUb
To understand how REV1 facilitates RAD18 binding on chromatin, we first examined the essential domains in REV1 for promoting RAD18 chromatin association and PCNA-mUb. 293T cells expressing a panel of REV1 peptides ( The ubiquitin cDNA lacking the C-terminal Gly-Gly codons was cloned to pEGFP-C3-REV1 UBM* plasmid to make a full-length REV1-ubiquitin chimera (REV1-Ub) (a mimic of monoubiquitinated REV1). We found that the REV1-Ub chimera failed to rescue the decreased PCNA-mUb resulting from UBMs* (Fig. 4C ).
This data suggest that REV1 does not likely facilitate PCNA-mUb via its monoubiquitination. Consistently, overexpression of REV1 WT, REV11-1123 and REV1653-1123 but not REV1 UBMs* and REV1-Ub, significantly increase UV-induced RAD18 focus formation ( Fig. 4D & E peptides which promote PCNA-mUb manifested increased REV1 focus formation after UV irradiation. Unlike WT REV1, REV11-1123 and REV1653-1123 did not exhibit increased REV1 focus formation (Fig. 4B, S4 ). Meanwhile, we also noticed that, unlike WT REV1, REV11-1123 and REV1653-1123 did not manifest an appreciable difference in the extent of their colocalization with PCNA after UV treatment compared with REV1 UBM* (Fig. S1C) , suggesting that the stimulatory effect of REV1 on PCNA-mUb is not likely mediated by its interaction with PCNA-mUb at stalled replication sites. Collectively, it hints at a possibility that another ubiquitinated protein(s) other than PCNA-mUb might be involved in this process.
REV1 binds RAD18-Ub to release RAD18 from RAD18-Ub/RAD18 complex
RAD18 in cells exhibits at least two different forms: an inactive, monoubiquitinated form (RAD18-mUb) and an active, nonubiquitinated form (Miyase et al., 2005; Zeman et al., 2014) . Recently, RAD18-mUb was reported to preferentially interact with nonubiquitinated RAD18 and thus prevent the latter from being recruited to the damaged DNA (Zeman et al., 2014) . We are wondering whether REV1 interacts with RAD18-mUb and thus releases RAD18 from RAD18-mUb/RAD18 complex. To test this hypothesis, we first examined the interaction between Flag-REV1 and GST-Ub-RAD18 or GST-RAD18. We found that REV1 bound more strongly to GST-Ub-RAD18 than to GST-RAD18 (Fig. 5A ).
Additionally, mutation of UBMs in REV1 significantly inhibited the binding of REV1
with GST-Ub-RAD18 (Fig. 5A ). To further confirm the finding, we purified His-tagged REV1653-1123 in both WT and UBMs* forms and examined their interactions with either GST-Ub-RAD18 or GST-RAD18. Like REV1 protein, His-REV1653-1123 WT manifested a much stronger binding with GST-Ub-RAD18
relative to its affinity to GST-RAD18 (Fig. 5B) .
Mutation of UBMs in
His-REV1653-1123 mostly eliminated the preferential binding of His-REV1653-1123 to
Journal of Cell Science • Advance article
GST-Ub-RAD18 (Fig. 5B) . Considering that mutation of L8A (with a leucine-to-alanine point mutation at L8) in ubiquitin could disrupt its association with the UBMs in REV1 (Bienko et al., 2005; Bomar et al., 2010) , we generated GST-Ub(L8A) and GST-Ub(L8A)-RAD18 chimera to check their interactions with REV1653-1123. Consistently, we found that mutation of L8A in ubiquitin significantly inhibited the binding between REV1653-1123 and ubiquitin or RAD18-Ub ( Fig. 5C and   D ), further confirming that the enhanced interaction between REV1 and RAD18-Ub is mediated by the ubiquitin on RAD18-Ub and REV1 UBMs. Additionally, we transfected WT and UBMs* Flag-REV1 into 293T cells followed by crosslinking and immunoprecipitation using anti-Flag M2 beads. Western blot analysis of the immunoprecipitated fractions showed that unmodified RAD18 associated weakly with both WT and UBM* REV1. In contrast, substantially more RAD18-mUb was coimmunoprecipitated with WT REV1 but not with the REV1 UBM* mutant (Fig.   5E ), further supporting preferential association of REV1 with ubiquitinated RAD18 than nonubiquitinated RAD18. We then determined whether REV1 affects the interaction between RAD18-mUb and RAD18. We co-transfected SFB-RAD18 and GFP-Ub-RAD18 into 293T cells and immunoprecipitated SFB-RAD18 with anti-Flag M2 beads. Then the beads were aliquoted and further incubated with increased amount of expressed GFP-REV1. Finally, the beads-bound proteins were analyzed through western blotting. We noted that the levels of coimmunoprecipitated GFP-Ub-RAD18 were negatively correlated with the amounts of supplemented GFP-REV1 (Fig. 5F ), suggesting that REV1 inhibits the interaction between RAD18
and RAD18-Ub. Furthermore, we examined whether this inhibitory effect requires the UBMs of REV1. We performed the similar competitive binding experiment as above, by incubating the aliquoted beads with cell lysates expressing WT or UBMs* REV1.
We found that mutation of UBMs in REV1 abrogated its inhibitory effect on the interaction between RAD18 and RAD18-Ub (Fig. 5G) . To confirm these results,
GST-Ub-RAD18 beads were aliquoted and incubated with equal amount of purified His-SUMO-RAD18 and increased amount of purified His-REV1653-1123. In line with the result shown in Fig. 5F , as more His-REV1653-1123 was supplemented, there were
Journal of Cell Science • Advance article an increase in His-REV1653-1123 binding and a decrease in His-SUMO-RAD18 binding to GST-Ub-RAD18 (Fig. 5H ). Compared to WT His-REV1653-1123, UBM* His-REV1653-1123 exhibited a weaker association to GST-Ub-RAD18 concomitantly with a less inhibitory effect on the interaction between GST-Ub-RAD18 and His-SUMO-RAD18 (Fig. 5I ). These results demonstrate that, through its UBMs, REV1 competes with RAD18 for binding to RAD18-mUb. As a corollary to this, nonubiquitinated RAD18 in RAD18-mUb/RAD18 complex is released, which allows more RAD18 to be recruited to chromatin for PCNA-mUb.
REV1 does not promote PCNA-mUb after exposure to MMS
In addition to UV radiation, multiple DNA damage treatments can also induce PCNA-mUb at stalled replication forks in mammalian cells (Kannouche et al., 2004; Niimi et al., 2008) . We then checked whether the stimulatory effect of REV1 on PCNA-mUb still occurs after exposure to other damage agents causing replication fork stalling. HU, MMC and MMS are commonly used DNA damage agents to induce replication stress and PCNA-mUb (Lin et al., 2011; Mailand et al., 2013; Hedglin and Benkovic, 2015) . MMC is a potent DNA crosslinker. HU stalls replication from depletion of nucleotide pools without eliciting DNA lesions, whereas MMS causes multiple DNA alkylation adducts that cannot be bypassed by the replicative DNA polymerases (Friedberg, 2006) . We exposed the 293T cells to HU, MMC or MMS, and examined the effect of REV1 on PCNA-mUb. We found that expression of REV1 still promoted PCNA-mUb after HU and MMC treatments, while it failed to stimulate PCNA-mUb after exposure to MMS (Fig. 6A & B) . Additionally, we noticed that RAD18-mUb could be detected after exposure to HU and MMC, but not MMS, which was recently reported to induce RAD18-mUb degradation (Zeman et al., 2014) . These data further support that the stimulatory effect of REV1 on PCNA-mUb is dependent on the RAD18-mUb. . In this work, we report that REV1 also modulates PCNA-mUb in the absence of DNA damage or after exposure to UVC, HU and MMC.
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Considering that REV1 interacts with Polη (Guo et al., 2003; Tissier et al., 2004) and Polη regulates PCNA-mUb (Durando et al., 2013), we examined whether the stimulatory effect of REV1 on PCNA-mUb was mediated by Polη. We found that over-expression of REV1 still promoted PCNA-mUb in the absence of Polη. In addition, we determined whether REV1 promoted PCNA-mUb through downregulating of USP1. We found that depletion of REV1 did not affect USP1 expression. Additionally, REV1 still enhanced PCNA-mUb in the USP1-depleted cells.
These data suggest that the stimulatory effect of REV1 on PCNA-mUb is not mediated by Polη or USP1.
Interestingly, we found that the stimulatory effect of REV1 on PCNA-mUb after UV radiation required its UBMs, indicating that this process might be mediated by an ubiquitinated protein. to be recruited to chromatin (Fig. 6C) . Consistently, the stimulatory effect of REV1 on PCNA-mUb was detected in cells exposed to examined DNA damage agents which do not abrogate RAD18-mUb, but not to MMS, an agent shown to remove RAD18-mUb (Zeman et al., 2014) . Together, our data reveal a novel role for REV1 in regulating PCNA-mUb and TLS pathway after certain types of DNA damage. Notably, our mode of regulation of REV1 on PCNA-mUb is distinctively different from that of Polη, which was recently reported to regulate PCNA-mUb depending on its recruitment to damage sites, its PIP boxes and its interaction with RAD18 (Durando et al., 2013; Masuda et al., 2015) .
REV1-mediated TLS is known to play a critical role in DNA damage-induced nucleotide substitutions in eukaryotes (Jansen et al., 2015) . In addition to functioning as a scaffold protein for polymerase switching at sites of lesions (Guo et al., 2003) , our data indicate that REV1 can promote PCNA-mUb in response to UV, HU and MMC, whose biological function(s) await further studies. The multiple regulatory roles of REV1 in error-prone TLS pathway make it a promising target for
Journal of Cell Science • Advance article chemotherapy. In support of that，recent studies using mouse lymphoma and prostate cancer models have shown that depletion of REV1 can remarkably inhibit drug-induced mutagenesis and sensitize cancer cells to chemotherapy (Xie et al., 2010; Xu et al., 2013) .
Materials and methods
Plasmids and reagents
Mouse Rev1 cDNA was cloned in pEGFP-C3 (Clontech) or p3xFlag-CMV (Sigma) to generate EGFP or Flag tagged proteins (named GFP-REV1 and Flag-REV1, respectively). A series of truncated mREV1 mutants were PCR amplified and cloned into pEGFP-C3. The constructs with mutations in mREV1 UBM domains were generated as described previously (Guo et al., 2006b ). WT and UBM* REV1653-1123-pET-16b expressing vectors were constructed through PCR amplification. The plasmids of pSFB-RAD18 (Flag-RAD18) and His-SUMO-RAD18
(His-RAD18) were gifts from Dr. Jun Huang (Zhejiang University, Hangzhou, China).
The cDNA of human RAD18 was cloned into pEGFP-C3 (Clontech) to generate the construct for expressing GFP-tagged RAD18 protein (GFP-RAD18). The ubiquitin cDNA lacking the C-terminal Gly-Gly codons was cloned into either pEGFP-C3-REV1 UBM* plasmid for expression of GFP-REV1-Ub chimera or pEGFP-C3-RAD18 plasmid for expression of GFP-Ub-RAD18 as previously described (Bienko et al., 2005; Zeman et al., 2014) . The PCR products of RAD18 and Ub-RAD18 were also subcloned into pGEX-4T-2 (GE Healthcare) for expression of GST-RAD18 and GST-Ub-RAD18 in E.coli. The mutant of GST-Ub(L8A)-RAD18
was prepared from GST-Ub-RAD18 by site-directed mutagenesis.
Anti-Flag M2 agarose affinity gel (A2220) and mouse monoclonal antibody against Flag (M2) (F3165) were purchased from Sigma-Aldrich (St Louis, MO).
Antibody against USP1 (D37B4) was from the Cell Signaling Technology (Danvers, MA Yang et al., 2015) .
Cell Culture and Reagents
Human U2OS (GAAAUACACAGCCAAGUAAUU) (Han et al., 2014) . The negative control siNC sequence (UUCUCCGAACGUGUCACGU) was obtained from GenePharma.
Establishment of RAD18 knockout cell lines
The RAD18 knocked out cells (RAD18KO) were established using TALEN-Tech as described previously (Sanjana et al., 2012) with some modifications. Briefly, the paired RAD18 TALEN arms were designed to target exon1 of RAD18. The sequences
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targeting RAD18 (L: ggactccctggccga; R: caccttcatgactgccag) were constructed into the backbone of pTALEN-L and pTALEN-R by one-step ligation using the Fast TALE TM TALEN Assembly kit (SIDANSAI Biotechnology, China), respectively. To get RAD18-deficient clones，HEK293T cells were transfected with a mixture of plasmids containing pTALEN-Rad18-L, pTALEN-Rad18-R, and pEGFP-C3 at a ratio of 9:9:2 in a 6 cm dish. One day later, the cells were incubated in media containing puromycin (1.2 μg/ml) for 3 days. Individual clones were isolated by limiting dilution and screened for RAD18 expression through western blot. Genomic DNA isolated from the RAD18KO cells was PCR amplified and the targeted exon of RAD18 was confirmed through sequencing.
Immunofluorescence
U2OS cells were UV irradiated and processed for immunofluorescence as described previously (Lv et al., 2013) . Briefly, before fixing in 4% paraformaldehyde, the cells were treated with 0.5% Triton X-100 for 10 to 30 min. Then the cells were blocked with 5% donkey serum (for RAD18 staining) or 5% BSA and 2% goat serum paraformaldehyde 4 h later after UV irradiation as described pr eviously (Guo et al., 2006a ). The cells with more than 40 REV1 foci were counted.
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Preparation of triton-insoluble fractions for western blotting
Triton-insoluble fractions were prepared as described previously (Kannouche et al., 2004) with modifications. Briefly, harvested cells were incubated with CSK100 buffer (100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 10 mM PIPES [pH 6.8], 1 mM EGTA, 0.2% Triton X-100) containing a cocktail of protease inhibitors for 20 min at 4°C. The pellets were lysed with buffer 1 (50 mM HEPES [pH 7.5], 50 mM NaCl, 0.05% SDS, 2 mM MgCl2, 10% Glycerol, 0.1% Triton X-100, 10 unit of RNase-free DNase I) containing a cocktail of protease inhibitors overnight. The supernatants were harvested followed by western blotting.
Proteins expression and purification in E. coli
GST fusion proteins (GST-RAD18, GST-Ub-RAD18 and GST-Ub(L8A)-RAD18) were expressed and purified as described previously (Zeman et al., 2014) . His-SUMO-RAD18 was expressed and purified as described previously (Han et al., 2014) . WT and UBM* His-REV1653-1123 were expressed in E. coli BL21 at 16°C overnight. Bacterial pellets were incubated with lysis buffer (50 mM Tris [pH 6.8], 300 mM NaCl, 1% Triton X-100, 10 mM imidazole, 1 mM PMSF, and 1 mM DTT) containing 1 mg/ml lysozyme (Sigma-Aldrich) for 1 h. After sonication, the lysates were clarified by centrifugation (12 000 g, 4°C, 30 min). The supernatant was incubated with Ni-NTA Agarose (Qiagen) for 2.5 h at 4°C. After washing with buffer (50 mM Tris [pH 6.8], 1 M NaCl, 1% Triton X-100, 10 mM imidazole), the proteins were eluted with buffer (50 mM Tris [pH 6.8], 300 mM NaCl, 1% Triton X-100, 250 mM imidazole and 1 mM DTT) and frozen at -80°C.
Coimmunoprecipitation and Western blotting
HEK293T cells transfected with WT and UBMs* Flag-REV1 were incubated with 1% formaldehyde for 15 min at room temperature to crosslink proteins. The reaction was stopped by a 5-min incubation with 0.1 M glycine. After twice washes with PBS, the cells were harvested and lysed with CSK100 buffer for 30 min at 4°C.
The supernatants after centrifugation were incubated with anti-Flag M2 beads
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GST pull down assay
For interaction between REV1 and GST-RAD18, REV1 expressing cells were lysed with HEPES buffer (50 mM Hepes [pH 7.4], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 10% glycerol, 10 uM ZnCl, 25 mM NaF) for 1 h at 4°C and then clarified by centrifugation. The supernatants were incubated with the indicated GST fusion proteins for 2.5 h at 4°C. For GST pull-down with purified proteins, the purified proteins were diluted in HEPES buffer and then incubated with the indicated GST proteins for 2.5 h at 4°C. After washing, the bound proteins were separated by SDS-PAGE and analyzed by western blot with indicated antibodies.
Competitive protein binding assays
To examine how REV1 affects the interaction between RAD18 and ubiquitinated RAD18, we transfected GFP-REV1 or SFB-RAD18 and GFP-Ub-RAD18 into 293T
cells. The cell lysates were harvested. SFB-RAD18 associated GFP-Ub-RAD18
were coimmunoprecipitated using anti-Flag M2 beads in HEPES buffer, then equal amount of beads were further incubated with different amount of REV1-expressing lysates. To directly determine how REV1 C-terminus affects the interaction between RAD18 and ubiquitinated RAD18, equal amount of GST-Ub-RAD18 protein was incubated with His-SUMO-RAD18 and increasing amounts of His-REV1653-1123. The bound proteins were separated by SDS-PAGE followed by immunoblotting with indicated antibodies. GST proteins were visualized by Ponceau S staining.
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